THE ROLE OF BASELINE CONCOMITANT USE OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS WITH TNF INHIBITORS IN SPONDYLOARTHRITIS PATIENTS

被引:0
|
作者
Akar, S. [1 ]
Kiraz, S. [2 ]
Gercik, O. [1 ]
Ertenli, I. [2 ]
Kucuksahin, O. [2 ]
Dalkilic, E. [3 ]
Bes, C. [4 ]
Kasifoglu, T. [5 ]
Emmungil, H. [6 ]
Koca, S. S. [7 ]
Cinar, M. [2 ]
Yazisiz, V. [8 ]
Dincer, B. Kelesoglu [2 ]
Ates, A. [2 ]
Kanitez, N. Alpay [4 ]
Erten, S. [2 ]
Turan, S. [6 ]
Pehlivan, Y. [3 ]
Oz, B. [7 ]
Bilge, S. Yasar [5 ]
Erden, A. [2 ]
Armagan, B. [2 ]
Coskun, B. N. [3 ]
Kalyoncu, U. [2 ]
机构
[1] TURKBIO Biol Registry, Izmir, Turkey
[2] TReasure Biol Registry, Ankara, Turkey
[3] TReasure Biol Registry, Bursa, Turkey
[4] TReasure Biol Registry, Istanbul, Turkey
[5] TReasure Biol Registry, Eskisehir, Turkey
[6] TReasure Biol Registry, Edirne, Turkey
[7] TReasure Biol Registry, Elazig, Turkey
[8] TReasure Biol Registry, Antalya, Turkey
关键词
D O I
10.1136/annrheumdis-2018-eular.4646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0297
引用
收藏
页码:1012 / 1013
页数:2
相关论文
共 50 条
  • [41] Radiographic outcome in Hispanic early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs
    Contreras-Yanez, Irazu
    Rull-Gabayet, Marina
    Vazquez-LaMadrid, Jorge
    Pascual-Ramos, Virginia
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 79 (02) : E52 - E57
  • [42] THE EFFECT OF BIOLOGICAL AND CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS ON FATIGUE IN FIBROMYALGIC RHEUMATOID ARTHRITIS PATIENTS
    Hizmetli, S.
    Durmaz, Y.
    Kaptanoglu, E.
    Cengiz, A. K.
    Peksen, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 864 - 864
  • [43] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AS A CAUSE OF IGA NEPHROPATHY
    Sulaiman, Abdullahi
    Shawwa, Khaled
    Shahrier, Amin
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S9 - S10
  • [44] New Disease modifying anti-rheumatic drugs (for Health Professionals)
    Forster, A.
    SWISS MEDICAL WEEKLY, 2009, 139 (7-8) : 4S - 4S
  • [45] PATIENT PREFERENCES IN THE CHOICE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Schiffner-Rohe, J.
    Alten, R.
    Krueger, K.
    Behmer, O. S.
    Schiffhorst, G.
    Rellecke, J.
    Nolting, H. D.
    VALUE IN HEALTH, 2014, 17 (07) : A385 - A385
  • [46] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A COHORT OF PATIENTS WITH IGG4-RELATED DISEASE
    Fernandez-Codina, A.
    Pinal-Fernandez, I.
    Orozco-Galvez, O.
    Solans-Laque, R.
    Bujan-Rivas, S.
    Fonollosa-Pla, V.
    Vilardell-Tarres, M.
    Martinez-Valle, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 398 - 398
  • [47] Tapering of Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients in Sustained Remission: Results from a Randomized Controlled Trial
    Lillegraven, Siri
    Sundlisater, Nina
    Aga, Anna-Birgitte
    Sexton, Joe
    Olsen, Inge Christoffer
    Fremstad, Hallvard
    Spada, Cristina
    Madland, Tor Magne
    Hoili, Christian
    Bakland, Gunnstein
    Lexberg, Ase
    Hansen, Inger Johanne Widding
    Hansen, Inger Myrnes
    Haukeland, Hilde
    Ljosa, Maud-Kristine Aga
    Moholt, Ellen
    Uhlig, Till
    Solomon, Daniel
    van der Heijde, Desiree
    Kvien, Tore
    Haavardsholm, Espen A.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study
    Joensuu, Jaana T.
    Aaltonen, Kalle J.
    Aronen, Pasi
    Sokka, Tuulikki
    Puolakka, Kari
    Tuompo, Riitta
    Korpela, Markku
    Vasala, Mikko
    Ilva, Kirsti
    Nordstrom, Dan
    Blom, Marja
    RHEUMATOLOGY, 2016, 55 (10) : 1803 - 1811
  • [49] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Machado, J.
    Ruiz, A.
    Machado-Duque, M.
    VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
  • [50] EFFICACY AND SAFETY OF UPADACITINIB IN A CHINESE SUBGROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Zeng, X.
    Liu, Y.
    Hu, J.
    Li, J.
    Wang, Y.
    Zhao, D.
    Wu, L.
    Xiao, Z.
    Li, Z.
    Xu, J.
    Meerwein, S.
    Xie, Y.
    Liang, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1324 - 1324